• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hsa_circ_0004712 的下调通过靶向 miR-331-3p/FZD4 通路抑制卵巢癌恶性进展。

Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway.

机构信息

Reproductive Medicine Center, Shenyang Women's and Children's Hospital, No. 87 Danan Street, Shenhe District, Shenyang, 110000, Liaoning, China.

Department of Radiology, Shenyang Women's and Children's Hospital, Shenyang, Liaoning, China.

出版信息

J Ovarian Res. 2021 Sep 10;14(1):118. doi: 10.1186/s13048-021-00859-0.

DOI:10.1186/s13048-021-00859-0
PMID:34507595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8434704/
Abstract

BACKGROUND

Circular RNAs (circRNAs) are gradually reported to be implicated in the development of malignant tumors, including ovarian cancer (OC). This paper intended to explore the function and action mechanism of hsa_circ_0004712 in OC.

RESULTS

In our results, hsa_circ_0004712 was aberrantly overexpressed in OC tissues and cells. Downregulation of hsa_circ_0004712 impaired OC cell proliferation, colony formation, invasion and migration, and accelerated apoptosis. Hsa_circ_0004712 directly targeted miR-331-3p whose inhibitors reversed the effects of hsa_circ_0004712 downregulation. FZD4 was targeted by miR-331-3p, and hsa_circ_0004712 could positively regulated FZD4 expression by targeting miR-331-3p. The anti-tumor effects of miR-331-3p restoration were reversed by FZD4 overexpression. Downregulation of hsa_circ_0004712 also impaired tumor development in vivo by regulating miR-331-3p and FZD4.

CONCLUSION

In conclusion, hsa_circ_0004712 deficiency repressed OC development by mediating the miR-331-3p/FZD4 pathway, predicting that hsa_circ_0004712 was a promising biomarker for OC diagnosis and therapy.

摘要

背景

环状 RNA(circRNAs)逐渐被报道与恶性肿瘤的发展有关,包括卵巢癌(OC)。本文旨在探讨 hsa_circ_0004712 在 OC 中的功能和作用机制。

结果

在我们的研究结果中,hsa_circ_0004712 在 OC 组织和细胞中异常高表达。下调 hsa_circ_0004712 抑制 OC 细胞增殖、集落形成、侵袭和迁移,并促进细胞凋亡。hsa_circ_0004712 可直接靶向 miR-331-3p,其抑制剂可逆转 hsa_circ_0004712 下调的作用。FZD4 是 miR-331-3p 的靶基因,hsa_circ_0004712 可通过靶向 miR-331-3p 正向调节 FZD4 表达。miR-331-3p 恢复的抗肿瘤作用可被 FZD4 过表达逆转。下调 hsa_circ_0004712 还通过调节 miR-331-3p 和 FZD4 抑制体内肿瘤的发展。

结论

综上所述,hsa_circ_0004712 缺失通过介导 miR-331-3p/FZD4 通路抑制 OC 发展,表明 hsa_circ_0004712 可能是 OC 诊断和治疗的有前途的生物标志物。

相似文献

1
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway.Hsa_circ_0004712 的下调通过靶向 miR-331-3p/FZD4 通路抑制卵巢癌恶性进展。
J Ovarian Res. 2021 Sep 10;14(1):118. doi: 10.1186/s13048-021-00859-0.
2
Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.环状 ACAP2 通过介导 miR-143-3p/FZD4 轴促进结直肠癌的进展。
Eur J Clin Invest. 2021 Dec;51(12):e13607. doi: 10.1111/eci.13607. Epub 2021 Jun 4.
3
Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.Hsa_circ_0001535 通过海绵吸附 miR-593-3p,上调 PTEN 表达,抑制卵巢癌细胞的增殖和迁移。
Clin Transl Oncol. 2023 Oct;25(10):2901-2910. doi: 10.1007/s12094-023-03152-2. Epub 2023 Mar 31.
4
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.RNA 结合蛋白 IGF2BP2 通过 microRNA-3187-3p/ERBB4/PI3K/AKT 轴增强卵巢癌细胞中 circ_0000745 的丰度,并促进其侵袭性和干性。
J Ovarian Res. 2021 Nov 13;14(1):154. doi: 10.1186/s13048-021-00917-7.
5
M6A-mediated hsa_circ_0061179 inhibits DNA damage in ovarian cancer cells via miR-143-3p/TIMELESS.M6A 介导的 hsa_circ_0061179 通过 miR-143-3p/TIMELESS 抑制卵巢癌细胞中的 DNA 损伤。
Mol Carcinog. 2024 Aug;63(8):1542-1558. doi: 10.1002/mc.23744. Epub 2024 May 15.
6
Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.Circ_0025033 缺失通过调节 miR-532-3p/FOXM1 网络抑制紫杉醇耐药卵巢癌细胞的紫杉醇耐药性和恶性发展。
Immunopharmacol Immunotoxicol. 2022 Apr;44(2):275-286. doi: 10.1080/08923973.2022.2038194. Epub 2022 Feb 24.
7
circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.circ_0025033 通过调控 hsa-miR-370-3p/SLC1A5 轴促进卵巢癌细胞的发展。
Cell Mol Biol Lett. 2022 Oct 22;27(1):94. doi: 10.1186/s11658-022-00364-2.
8
Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR‑124‑3p/EZH2 signaling pathway.hsa_circ_0026123 的下调通过 miR-124-3p/EZH2 信号通路抑制卵巢癌细胞转移和增殖。
Int J Mol Med. 2021 Feb;47(2):668-676. doi: 10.3892/ijmm.2020.4804. Epub 2020 Dec 1.
9
Hsa_circ_0013561 promotes epithelial-mesenchymal transition and tumor progression by regulating ANXA2 via miR-23b-3p in ovarian cancer.在卵巢癌中,hsa_circ_0013561通过miR-23b-3p调控膜联蛋白A2(ANXA2),从而促进上皮-间质转化和肿瘤进展。
Cancer Gene Ther. 2024 Jan;31(1):108-118. doi: 10.1038/s41417-023-00686-z. Epub 2023 Dec 15.
10
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.环状 RNA circ-BNC2 (hsa_circ_0008732) 通过 microRNA-223-3p/FBXW7 轴抑制卵巢癌的进展。
J Ovarian Res. 2022 Aug 14;15(1):95. doi: 10.1186/s13048-022-01025-w.

引用本文的文献

1
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation.癌症中的Wnt信号传导:从生物标志物到靶向治疗及临床转化
Mol Cancer. 2025 Apr 2;24(1):107. doi: 10.1186/s12943-025-02306-w.
2
Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.微小RNA与环状RNA在上皮性卵巢癌中的相互作用
Noncoding RNA. 2024 Sep 30;10(5):51. doi: 10.3390/ncrna10050051.
3
Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical Models: Identification of Targets and New Modalities for Therapeutic Intervention.

本文引用的文献

1
MicroRNA-331-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2.微小RNA-331-3p通过靶向RCC2抑制卵巢癌的增殖和转移。
Arch Med Sci. 2019 Oct;15(6):1520-1529. doi: 10.5114/aoms.2018.77858. Epub 2018 Aug 28.
2
Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer.分析和生物信息学分析揭示了卵巢癌中差异的环状 RNA 表达。
Gene. 2020 Jan 15;724:144150. doi: 10.1016/j.gene.2019.144150. Epub 2019 Oct 4.
3
Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients.
上皮性卵巢癌中失调的 circRNAs 在临床前模型中的活性:靶标的鉴定和治疗干预的新方法。
Cancer Genomics Proteomics. 2024 Apr 26;21(3):213-237. doi: 10.21873/cgp.20442.
4
CircECE1 promotes osteosarcoma progression through regulating RAB3D by sponging miR-588.环状 RNA ECE1 通过海绵吸附 miR-588 调控 RAB3D 促进骨肉瘤进展。
J Orthop Surg Res. 2023 Aug 9;18(1):587. doi: 10.1186/s13018-023-04045-4.
5
Circ_0005615 restrains the progression of multiple myeloma through modulating miR-331-3p and IGF1R regulatory cascade.环状 RNA 0005615 通过调控 miR-331-3p 和 IGF1R 调控级联抑制多发性骨髓瘤的进展。
J Orthop Surg Res. 2023 May 12;18(1):356. doi: 10.1186/s13018-023-03832-3.
6
Silencing hsa_circ_0049271 attenuates hypoxia-reoxygenation (H/R)-induced myocardial cell injury via the miR-17-3p/FZD4 signaling axis.沉默hsa_circ_0049271通过miR-17-3p/FZD4信号轴减轻缺氧复氧(H/R)诱导的心肌细胞损伤。
Ann Transl Med. 2023 Jan 31;11(2):99. doi: 10.21037/atm-22-6331.
7
Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.外泌体 circNFIX 通过 miR-518a-3p/TRIM44 轴促进卵巢癌血管生成。
Kaohsiung J Med Sci. 2023 Jan;39(1):26-39. doi: 10.1002/kjm2.12615. Epub 2022 Nov 30.
8
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets.上皮性卵巢癌中的环状RNA:从生物标志物到治疗靶点
Cancers (Basel). 2022 Nov 21;14(22):5711. doi: 10.3390/cancers14225711.
9
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.环状RNA在卵巢癌中的新兴作用及潜在应用:综述
J Cancer Res Clin Oncol. 2023 May;149(5):2211-2234. doi: 10.1007/s00432-022-04328-z. Epub 2022 Sep 2.
10
Emerging role of circular RNAs in the pathogenesis of ovarian cancer.环状RNA在卵巢癌发病机制中的新作用。
Cancer Cell Int. 2022 Apr 29;22(1):172. doi: 10.1186/s12935-022-02602-1.
Wnt/β-连环蛋白信号通路中TCF1表达在原发性乳腺癌患者中的独立负性预后作用
Cancers (Basel). 2019 Jul 22;11(7):1035. doi: 10.3390/cancers11071035.
4
Circular RNA circ-SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6.环状 RNA circ-SMAD7 通过抑制 KLF6 促进卵巢癌细胞增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5603-5610. doi: 10.26355/eurrev_201907_18294.
5
Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.环状 RNA CircCACTIN 通过海绵吸附 miR-331-3p 并调节 TGFBR1 表达促进胃癌进展。
Int J Biol Sci. 2019 Apr 22;15(5):1091-1103. doi: 10.7150/ijbs.31533. eCollection 2019.
6
circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.环状 CSPP1 通过作为 miR-1236-3p 的海绵吸附子促进卵巢癌细胞的增殖、侵袭和迁移。
Biomed Pharmacother. 2019 Jun;114:108832. doi: 10.1016/j.biopha.2019.108832. Epub 2019 Apr 11.
7
Inhibition of the Hepatocellular Carcinoma (HCC) Bel-7402 Cell Line by Down-Regulation of E2F1.下调 E2F1 抑制肝癌 Bel-7402 细胞系。
J Nanosci Nanotechnol. 2019 Sep 1;19(9):5476-5482. doi: 10.1166/jnn.2019.16535.
8
MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer.微小 RNA-331-3p 通过 Rac1/PAK1/β-连环蛋白轴靶向 ErbB2 和 VAV2 抑制非小细胞肺癌中的上皮-间充质转化。
Cancer Sci. 2019 Jun;110(6):1883-1896. doi: 10.1111/cas.14014. Epub 2019 Apr 29.
9
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.高级别浆液性卵巢癌:基础科学、临床和治疗观点。
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
10
The Landscape of Circular RNA in Cancer.环状 RNA 在癌症中的研究进展
Cell. 2019 Feb 7;176(4):869-881.e13. doi: 10.1016/j.cell.2018.12.021.